Latest News

Panel releases guidelines for red meat, processed meat consumption

View on the News

It may be time to reconsider how we communicate nutrition information to populations

The new guidelines for red meat and processed meat consumption will be controversial. Since it is based on a review of all available data on red meat and processed meat consumption; however, it will be difficult to find evidence to argue against it, wrote Aaron E. Carroll, MD, MS; and Tiffany S. Doherty, PhD, in a related editorial.

Further, many participants in a systematic review by Valli and colleagues expressed beliefs that they had already reduced their meat consumption. Additionally, some cited mistrust of the information presented by studies as their explanation for not reducing meat consumption, according to Dr. Carroll and Dr. Doherty (Ann Intern Med. 2019 Oct 1. doi: 10.7326/M19-2620). “It’s not even clear that those who disbelieve what they hear about meat are wrong,” they added. “We have saturated the market with warnings about the dangers of red meat. It would be hard to find someone who doesn’t ‘know’ that experts think we should all eat less. Continuing to broadcast that fact, with more and more shaky studies touting potential small relative risks, is not changing anyone’s mind.”

Dr. Carroll and Dr. Doherty proposed that more study in this area with smaller cohorts may be of limited value, and randomized trials should be conducted in areas where we “don’t already know” the information.

The authors also called for efforts to be made to discuss reasons to reduce meat consumption unrelated to health.

“Ethical concerns about animal welfare can be important, as can concerns about the effects of meat consumption on the environment,” they concluded. “Both of these issues might be more likely to sway people, and they have the added benefit of empirical evidence behind them. And if they result in reducing meat consumption, and some receive a small health benefit as a side effect, everyone wins.”

Dr. Carroll and Dr. Doherty are from the Center for Pediatric and Adolescent Comparative Effectiveness Research, Indiana University, Indianapolis. These comments reflect their editorial in response to Johnston et al. Dr. Carroll reports receiving royalties for a book he wrote on nutrition; Dr. Doherty reports no relevant conflicts of interest.


 

FROM ANNALS OF INTERNAL MEDICINE

People who eat red meat or processed meat should continue their current meat consumption, according to recent guidelines from an international panel that were recently published in the Annals of Internal Medicine.

A shopper reads the label on a package of red meat. Fuse/Thinkstock

This recommendation was based on the panel having found “low- to very-low-certainty evidence that diets lower in unprocessed red meat may have little or no effect on the risk for major cardiometabolic outcomes and cancer mortality and incidence.” Additionally, meta-analysis results from 23 cohort studies provided low- to very-low-certainty evidence that decreasing unprocessed red meat intake may result in a very small reduction in the risk for major cardiovascular outcomes and type 2 diabetes, with no statistically differences in all-cause mortality and cardiovascular mortality, the guidelines say.

“Our weak recommendation that people continue their current meat consumption highlights both the uncertainty associated with possible harmful effects and the very small magnitude of effect, even if the best estimates represent true causation, which we believe to be implausible,” Bradley C. Johnston, PhD, of the department of community health and epidemiology at Dalhousie University, Halifax, N.S., and colleagues wrote in their paper summarizing the panel’s guidelines.

The evidence Dr. Johnston and colleagues examined were from four systematic reviews analyzing the health effects of red meat and processed meat consumption in randomized trials and meta-analyses of cohort studies as well as one systematic review that identified how people viewed their consumption of meat and values surrounding meat consumption.

In one review of 12 randomized trials examining diets of high and low red meat consumption, a diet consisting of low red meat had little effect on cardiovascular mortality (hazard ratio, 0.98; 95% confidence interval, 0.91-1.06), cardiovascular disease (HR, 0.99; 95% CI, 0.94-1.05), all-cause mortality (0.99; 95% CI, 0.95-1.03) and total cancer mortality (HR, 0.95; 95% CI, 0.89-1.01), including on colorectal cancer or breast cancer (Zeraatkar D et al. Ann Intern Med. 2019 Oct 1. doi: 10.7326/M19-0622). A different review of observational cohort studies with more than 1,000 participants found “very-small or possibly small decreases” in all-cause mortality, incidence, and all-cause mortality of cancer, cardiovascular mortality, nonfatal coronary heart disease and MI, and type 2 diabetes for patients who had a diet low in red meat or processed meat (Vernooij R et al. Ann Intern Med. 2019 Oct 1. doi: 10.7326/M19-1583); a second review by Zeraatkar and colleagues of 55 observational cohort studies with more than 4 million participants found three servings of unprocessed red meat and processed meat per week was associated with a “very small reduction” in risk for MI, stroke, type 2 diabetes, cardiovascular mortality, and all-cause mortality (Zeraatkar D et al. Ann Intern Med. 2019 Oct 1. doi: 10.7326/M19-1326). Another systematic review of 56 observational cohort studies found three servings of unprocessed red meat per week was associated with a slight reduction in overall cancer mortality (Han MA et al. Ann Intern Med. 2019 Oct 1. doi: 10.7326/M19-0699).

The authors also performed a systematic review of participant preferences and values regarding meat consumption. The evidence from 54 qualitative studies showed omnivores preferred eating meat, considered it part of a healthy diet, “lack[ed] the skills needed” to prepare meals without meat, and were mostly unwilling to change their meat consumption (Valli C et al. Ann Intern Med. 2019. doi: 10.7326/M19-1326).

“There was a very small and often trivial absolute risk reduction based on a realistic decrease of three servings of red or processed meat per week,” Dr. Johnston and colleagues wrote in their guidelines. If the very-small exposure effect is true, given peoples’ attachment to their meat-based diet, the associated risk reduction is not likely to provide sufficient motivation to reduce consumption of red meat or processed meat in fully informed individuals, and the weak, rather than strong, recommendation is based on the large variability in peoples’ values and preferences related to meat.”

The authors noted they did not examine factors such as cost, acceptability, feasibility, equity, environmental impact, and views on animal welfare when creating the guidelines. In addition, the low level of evidence from the randomized trials and observational studies means that the potential benefits of reducing red meat or processed meat intake may not outweigh the cultural and personal preferences or quality of life issues that could arise from changing one’s diet.

“This assessment may be excessively pessimistic; indeed, we hope that is the case,” they said. “What is certain is that generating higher-quality evidence regarding the magnitude of any causal effect of meat consumption on health outcomes will test the ingenuity and imagination of health science investigators.”

Dr. El Dib reported receiving funding from the São Paulo Research Foundation, the National Council for Scientific and Technological Development, and the faculty of medicine at Dalhousie University. Dr. de Souza reports relationships with the Canadian Institutes of Health Research/Health Canada, the Canadian Foundation for Dietetic Research and the World Health Organization in the forms of personal fees, grants, and speakers bureau and board of directorship appointments. Dr. Patel reports receiving grants and person fees from the National Institutes of Health, Sanofi, the National Science Foundation, XY.health, doc.ai, Janssen, and the CDC.

SOURCE: Johnston B et al. Ann Intern Med. 2019 Oct 1. doi: 10.7326/M19-1621.

Recommended Reading

Machine learning–derived risk score predicts heart failure risk in diabetes patients
MDedge Cardiology
Beta-blockers effective, safe for HFrEF with renal dysfunction
MDedge Cardiology
Skip supplemental O2 in nonhypoxic ACS
MDedge Cardiology
Dual therapy best for AFib with ACS no matter the treatment strategy
MDedge Cardiology
AF risk is elevated after early-stage breast cancer diagnosis
MDedge Cardiology
Ticagrelor monotherapy tops DAPT for high-risk PCI patients
MDedge Cardiology
MitraClip learning curve may top 200 cases
MDedge Cardiology
Cardiotoxicity after checkpoint inhibitor treatment seen early, linked to elevated biomarkers
MDedge Cardiology
Heart disease raises risk of severe cutaneous adverse reactions to allopurinol
MDedge Cardiology
FDA adds diabetic kidney disease, heart failure indications to canagliflozin
MDedge Cardiology